Euroconference Mastering Anti-Infective Therapies (Anti-Infective)

Venue: Institut Pasteur - CIS

Location: Paris, France

Event Date/Time: Oct 20, 2005 End Date/Time: Oct 21, 2005
Early Registration Date: Sep 20, 2005
Abstract Submission Date: Sep 01, 2005
Report as Spam


the global increase of resistant pathogens both in the community and hospitals, the emergence of new pathogens with their own potential intrinsic resistance, the existence of co-infections, and the increased number of susceptible hosts such as those iatrogenically immunodepressed and elderly. Regarding antimicrobial resistance, the World Health Organization Assembly in May 2005, will discuss one of the resolutions that deal with this worrying problem. European Union has already committed itself to combating resistance to anti-infective therapies, particularly antibiotic resistance.Among other initiatives, EU has banned antibiotics as growth-promoting additives to animal feed and favoured policy to limit their unrestricted use in clinical medicine. Nowadays, it is essential that all parties, practising physicians, academic researchers, industry and politicians join forces to combat antiinfective agents resistance. Furthermore, the problem is increased with the insufficient development of new and effective drugs targeting resistant micro-organisms. In addition, the economical cost of new anti-infective agents, which concerns both industrialized and developing countries, has to be taken into account.The Institut Pasteur holds a prime position in the world in research on infections and their treatment. In EUROCONFERENCE in Paris 20-21 October, 2005, leading scientists will present state-of-the-art in the field of anti-infective therapy, discuss the above issues and outline fields for future research and hope.


28 rue du Dr Roux